Nucleic Acids Research, 1994, Vol. 22, No. 12 2417-2422
© 1994
MOLECULAR BIOLOGY |
Apo CIII gene transcription is regulated by a cytokine inducible NF-
B element
1Department of Biotechnology Parke-Davis, 2800 Plymouth Rd, Ann Arbor, MI 48105 2Department of Biological Chemistry, University of Michigan Ann Arbor, MI 48104 3Biochemical Genetics and Metabolism, The Rockefeller University New York, NY 10021, USA
*To whom correspondence should be addressed at: Department of Biotechnology, Parke-Davis, 2800 Plymouth Rd, Ann Arbor, MI 48105, USA
Received October 28, 1993. Revised December 22, 1993. Accepted May 17, 1994.
Overproduction of Apo CIII causes elevated plasma triglyceride levels in transgenic animals and is associated with hypertriglyceridemia in humans. The regulation of apo CIII production is likely to play an important role in controlling plasma triglyceride levels. As an initial step in determining the role of transcriptional regulation in the production of apo CIII and in triglyceride metabolism, we have begun to characterize the activity of specific transcriptional regulatory elements in the CIII promoter. In the current study, we have identified and characterized an NF-
B regulatory element located 150 nucleotides upstream from the transcriptional start site of the apo CIII gene. Purified NF-B, as well as an NF-B protein in HepG2 cell nuclear extracts, bound specifically to this sequence element. The hepatic protein was induced by phorbol ester (PMA), and reacted with antibodies to the p50 and p65 subunits of NF-B. The NF-B element conferred PMA and IL1-ß inducible transcriptional activity to a heterologous promoter/reporter construct when transfected into HepG2 cells. Analysis of the full length CIII promoter demonstrated that the inducible activity of the NF-B element was suppressed by sequences in the apo CIII enhancer element located approximately 500 nucleotides upstream of the NF-B binding site. A deletion removing the enhancer restored the PMA inducible activity of the NF-B binding site. These results indicate that apo CIII gene expression is regulated by NF-B, and suggest that apo CIII production may be modulated by cellular signals, like inflammatory cytokines, that activate NF-kB.
+Present addresses: Departmem of Surgery, Johns Hopkins Hospital, 401 North Wolfe Street, Baltimore, MD 21287-4618, USA
Abbot Diagnostic Inc., PO box 278, Barceloneta, Puerto Rico 00617
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Reddy, W. Yang, D. G. Taylor, X.-q. Shen, D. Oxender, G. Kust, and T. Leff Mitogen-activated Protein Kinase Regulates Transcription of the ApoCIII Gene. INVOLVEMENT OF THE ORPHAN NUCLEAR RECEPTOR HNF4 J. Biol. Chem., November 12, 1999; 274(46): 33050 - 33056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Loser, G. S. Jennings, M. Strauss, and V. Sandig Reactivation of the Previously Silenced Cytomegalovirus Major Immediate-Early Promoter in the Mouse Liver: Involvement of NFkappa B J. Virol., January 1, 1998; 72(1): 180 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Lacorte, E. Ktistaki, A. Beigneux, V. I. Zannis, J. Chambaz, and I. Talianidis Activation of CAAT Enhancer-binding Protein delta (C/EBPdelta ) by Interleukin-1 Negatively Influences Apolipoprotein C-III Expression J. Biol. Chem., September 19, 1997; 272(38): 23578 - 23584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Surguchov, G. P. Page, L. Smith, W. Patsch, and E. Boerwinkle Polymorphic Markers in Apolipoprotein C-III Gene Flanking Regions and Hypertriglyceridemia Arterioscler. Thromb. Vasc. Biol., August 1, 1996; 16(8): 941 - 947. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Kardassis, M. Laccotripe, I. Talianidis, and V. Zannis Transcriptional Regulation of the Genes Involved in Lipoprotein Transport : The Role of Proximal Promoters and Long-range Regulatory Elements and Factors in Apolipoprotein Gene Regulation Hypertension, April 1, 1996; 27(4): 980 - 1008. [Full Text]
|
|
|
|
|
|
R. H. J. B.-S. and Jacob Bar-Tana and R. Hertz Mode of Action of Peroxisome Proliferators as Hypolipidemic Drugs J. Biol. Chem., June 2, 1995; 270(22): 13470 - 13475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Raspe, H. Duez, P. Gervois, C. Fievet, J.-C. Fruchart, S. Besnard, J. Mariani, A. Tedgui, and B. Staels Transcriptional Regulation of Apolipoprotein C-III Gene Expression by the Orphan Nuclear Receptor RORalpha J. Biol. Chem., January 19, 2001; 276(4): 2865 - 2871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Kardassis, K. Pardali, and V. I. Zannis SMAD Proteins Transactivate the Human ApoCIII Promoter by Interacting Physically and Functionally with Hepatocyte Nuclear Factor 4 J. Biol. Chem., December 22, 2000; 275(52): 41405 - 41414. [Abstract] [Full Text] [PDF]
|
|